A groundbreaking early-stage clinical trial is offering new hope in the fight against pancreatic cancer. Researchers have developed a personalized mRNA vaccine designed to train the immune system to recognize and attack cancer cells—and early
Recent federal budget decisions signal renewed national momentum for cancer research—including meaningful progress for pancreatic cancer. In March 2026, Congress
No one expects to be told they have pancreatic cancer in the emergency room, with less than a 1% chance of survival, but that’s exactly what happened to Greg Adams. Determined to find another path,
Sky Foundation created the Shine Like Sheila Award to honor the legacy of founder and pancreatic cancer survivor Sheila Kasselman, whose passion and perseverance continue to guide our mission. Sheila dedicated her life to raising
UCLA’s Dr. Zev Wainberg discusses results from the AMPLIFY-201 trial and hopes for next-generation vaccines. Researchers are exploring new ways to fight pancreatic cancer, one of the toughest cancers to treat. A recent phase 1
Independent committee recommends ELI-002 7P Phase 2 study continue without changes. Elicio Therapeutics has announced encouraging news for its pancreatic
Sky Foundation is proud to highlight the success of a rising cancer researcher from the lab of Dr. Asfar Azmi at Karmanos Cancer Institute and Wayne State University. Husain Yar Khan, Ph.D. was awarded the
Biobank of tumor tissue and advanced molecular profiling steer researchers toward new targeted therapies Other than a fleeting moment in high school when she thought about becoming a pianist, Eileen Carpenter, M.D., Ph.D., has always had
Congratulations to our very own Leigh Settemoir Ph.D., MBA, SPHR on receiving Oakland University's Staff Excellence Award in Community Engagement. Leigh is Assistant Dean of the School of Health Sciences at Oakland University, where
Kate's, the Princess of Wales, diagnosis of cancer at the young age of 42 years has caught many by surprise, but it is part of a startling growing trend. A medical oncologist weighs in on
Very hopeful news! Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced that it will be the first provider in the country to offer